Akeso's Phase II trials of AK146D1 and AK138D1 approved in China

Insilico Medicine and ASKA Pharmaceutical expand partnership on women's health targets

Sanofi and Regeneron's Dupixent gains Japan approval as first targeted therapy for bullous pemphigoid

Pharming secures Japan approval for Joenja in rare immune disorder treatment

BioArctic and Eisai present new lecanemab and exidavnemab data at AD/PD 2026

HUTCHMED launches Phase III trial of HMPL-760 for DLBCL in China

Pfizer and Valneva report strong Phase 3 results for Lyme disease vaccine candidate

Futura Medical reports positive home user test results for Eroxon and Intense variant

GSK secures Japan Orphan Drug status for lung cancer ADC

TheraCryf advances lead addiction programme to final preclinical stage

Dizal meets primary endpoint in Phase 3 study of ZEGFROVY (sunvozertinib) monotherapy

Innovent Biologics reports first participant dosed in tigulixostat Phase 3 study

Novartis to acquire PI3K-alpha inhibitor program from Synnovation in deal worth up to USD3bn

Humacyte prices USD20m registered direct offering

Curia expands Glasgow manufacturing capacity and enhances CLD platform